Novartis is transforming into a ‘pure-play’ Innovative Medicines company.

In this video, Shreeram Aradhye, President, Global Drug Development & Chief Medical Officer at Novartis discusses how Novartis is focusing on high priority programs, clear regulatory strategies, and relentless operational discipline. These are central to our drug development and pipeline approach as we transform Novartis into a ‘pure play’ Innovative Medicines company.

Meet Novartis Management
Event Date: September 22, 2022
Investors Page: [ Ссылка ]
Link to Novartis Strategy: [ Ссылка ]

Disclaimer: Meet Novartis Management event contains forward-looking statements. Such forward-looking statements are subject to significant known and unknown risks and uncertainties. Visit our website for more information: [ Ссылка ]

Follow @Novartis on Twitter: [ Ссылка ]
Follow Novartis on LinkedIn: [ Ссылка ]

свернуть